Back to Agenda
KEYNOTE SESSION
Session Chair(s)
Ari Fujishiro
Senior Director, Regulatory Affairs Group, Asia Development Dept., R&D Division
Daiichi Sankyo Co., Ltd., Japan
Hidetoshi Shuto
Senior Fellow, Corporate Technology Sector
Nitto Denko Corporation, Japan
Speaker(s)
New Drug Development in Asian Region - from Japanese Company Perspective
Hidetoshi Shuto
Nitto Denko Corporation, Japan
Senior Fellow, Corporate Technology Sector
Strategies for Asia Drug Development: An Integrated Approach
Mark Bach, MD, PhD
Johnson & Johnson, United States
Vice President, Office of the Chief Medical Officer
Have an account?